Tokyo, Japan

Masayuki Shimoda

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Masayuki Shimoda: Innovator in Cancer Treatment

Introduction

Masayuki Shimoda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development of antibodies. With a total of 3 patents, Shimoda's work focuses on targeting specific proteins involved in cancer progression.

Latest Patents

Shimoda's latest patents include groundbreaking inventions aimed at combating cancer. One of his notable patents is the development of an Anti-ADAM28 antibody for treating cancer. This invention provides an antibody that specifically binds to human ADAM28, inhibiting its enzyme activity and suppressing the metastasis of cancer cells expressing this protein. Another significant patent is the Anti-human membrane-type ADAM28 antibody, which specifically binds to the membrane-anchored form of ADAM28. This antibody can be utilized as a drug delivery vehicle to target cells or tissues expressing human membrane-anchored ADAM28.

Career Highlights

Throughout his career, Masayuki Shimoda has worked with esteemed organizations such as Genefrontier Corporation and Keio University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Shimoda has collaborated with notable colleagues, including Akira Miyakoshi and Satsuki Mochizuki. These partnerships have fostered a collaborative environment that enhances the innovation process in cancer research.

Conclusion

Masayuki Shimoda's contributions to cancer treatment through his patented inventions highlight his role as a leading inventor in the field. His innovative approaches to targeting cancer-related proteins demonstrate the potential for advancements in therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…